Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Coherus BioSciences, Inc. (CHRS) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 8-K Unregistered Sales of Equity Securities  Interactive Data
10/06/2023 SC 13G/A BlackRock Inc. reports a 10.9% stake in COHERUS BIOSCIENCES INC
08/02/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Quarterly results
07/27/2023 EFFECT Form EFFECT - Notice of Effectiveness:
07/26/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
07/24/2023 S-4/A Form S-4/A - Registration of securities, business combinations: [Amend]
07/20/2023 8-K Quarterly results
07/07/2023 S-4 Form S-4 - Registration of securities, business combinations:
06/16/2023 425 Form 425 - Prospectuses and communications, business combinations:
06/16/2023 425 Form 425 - Prospectuses and communications, business combinations:
06/16/2023 425 Form 425 - Prospectuses and communications, business combinations:
06/16/2023 425 Form 425 - Prospectuses and communications, business combinations:
06/16/2023 425 Form 425 - Prospectuses and communications, business combinations:
06/16/2023 425 Form 425 - Prospectuses and communications, business combinations:
06/16/2023 425 Form 425 - Prospectuses and communications, business combinations:
06/16/2023 425 Form 425 - Prospectuses and communications, business combinations:
06/16/2023 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "Agreement and Plan of Merger, by and among Coherus BioSciences, Inc., Crimson Merger Sub I, Inc., Crimson Merger Sub II, LLC and Surface Oncology, Inc., (Form of CVR Agreement included as Exhibit A thereto)",
"Coherus to Acquire Surface Oncology"
06/09/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/31/2023 8-K Other Events  Interactive Data
05/19/2023 SC 13G CITADEL ADVISORS LLC reports a 6.2% stake in Coherus Biosciences, Inc.
05/18/2023 8-K Asset disposition
Docs: "Underwriting Agreement, among Coherus BioSciences, Inc. and J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as representatives of the several underwriters named therein",
"Opinion of Latham & Watkins LLP"
05/16/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/15/2023 8-K Entry into a Material Definitive Agreement  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
05/08/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/08/2023 8-K Quarterly results
04/17/2023 ARS Form ARS - Annual Report to Security Holders:
04/17/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/17/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/06/2023 10-K Annual Report for the period ended December 31, 2022
03/06/2023 8-K Quarterly results
02/14/2023 SC 13G/A PERCEPTIVE ADVISORS LLC reports a 0% stake in Coherus BioSciences, Inc.
02/03/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/18/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy